UY37824A - CRYSTAL FORM OF ACID (2S) -2 - [[(Z) - [1- (2-AMINO-4-TIAZOLIL) -2 - [[(3S) -2,2-DIMETIL-4-OXO-1- ( SULFOXI) -3-AZETIDINIL] AMINO] -2-OXOETILIDEN] AMINO] OXI] -3- [4- [IMINO [(3R) -3-PIPERIDINYLAMINE] METHYL] PHENOXY] -PROPANOIC - Google Patents
CRYSTAL FORM OF ACID (2S) -2 - [[(Z) - [1- (2-AMINO-4-TIAZOLIL) -2 - [[(3S) -2,2-DIMETIL-4-OXO-1- ( SULFOXI) -3-AZETIDINIL] AMINO] -2-OXOETILIDEN] AMINO] OXI] -3- [4- [IMINO [(3R) -3-PIPERIDINYLAMINE] METHYL] PHENOXY] -PROPANOICInfo
- Publication number
- UY37824A UY37824A UY0001037824A UY37824A UY37824A UY 37824 A UY37824 A UY 37824A UY 0001037824 A UY0001037824 A UY 0001037824A UY 37824 A UY37824 A UY 37824A UY 37824 A UY37824 A UY 37824A
- Authority
- UY
- Uruguay
- Prior art keywords
- amino
- imino
- phenoxy
- oxo
- methyl
- Prior art date
Links
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 title 1
- 102100037189 Sodium- and chloride-dependent transporter XTRP3 Human genes 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 title 1
- -1 2-amino-4-thiazolyl Chemical group 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a la primera forma cristalina del ácido (2S)-2-[[(Z)-[1-(2-amino-4-tiazolil)-2-[[(3S)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3R)-3- piperidinilamino]metil]fenoxi]-propanoico, es decir, el compuesto de fórmula (I).The invention relates to the first crystalline form of (2S) -2 - [[((Z) - [1- (2-amino-4-thiazolyl) -2 - [[((3S) -2,2-dimethyl- 4-oxo-1- (sulfoxy) -3-azetidinyl] amino] -2-oxoethylidene] amino] oxy] -3- [4- [imino [(3R) -3-piperidinylamino] methyl] phenoxy] -propanoic acid, is ie, the compound of formula (I).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17183862 | 2017-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37824A true UY37824A (en) | 2019-02-28 |
Family
ID=59485296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037824A UY37824A (en) | 2017-07-28 | 2018-07-27 | CRYSTAL FORM OF ACID (2S) -2 - [[(Z) - [1- (2-AMINO-4-TIAZOLIL) -2 - [[(3S) -2,2-DIMETIL-4-OXO-1- ( SULFOXI) -3-AZETIDINIL] AMINO] -2-OXOETILIDEN] AMINO] OXI] -3- [4- [IMINO [(3R) -3-PIPERIDINYLAMINE] METHYL] PHENOXY] -PROPANOIC |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR112464A1 (en) |
TW (1) | TW201920163A (en) |
UY (1) | UY37824A (en) |
WO (1) | WO2019020810A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111592536B (en) * | 2020-06-04 | 2023-11-03 | 宁夏农林科学院农业资源与环境研究所(宁夏土壤与植物营养重点实验室) | Monocyclic beta-lactam compound, preparation method and application thereof |
CN115210231B (en) * | 2020-07-16 | 2024-10-08 | 宁夏农林科学院 | Monocyclic lactams, process for their preparation and their use as antibacterial agents |
US20230150996A1 (en) * | 2020-08-06 | 2023-05-18 | Ningxia Academy Of Agriculture And Forestry Sciences | B-lactam compounds, their preparation and use as antibacterial agents |
IL312841A (en) | 2021-11-18 | 2024-07-01 | Merck Sharp & Dohme Llc | Chromane amidine monobactam antibiotics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY34585A (en) | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | B-LACTAMIC COMPOUNDS REPLACED WITH AMIDINE, ITS PREPARATION AND USE |
-
2018
- 2018-07-27 WO PCT/EP2018/070475 patent/WO2019020810A1/en active Application Filing
- 2018-07-27 TW TW107126077A patent/TW201920163A/en unknown
- 2018-07-27 AR ARP180102116 patent/AR112464A1/en unknown
- 2018-07-27 UY UY0001037824A patent/UY37824A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR112464A1 (en) | 2019-10-30 |
TW201920163A (en) | 2019-06-01 |
WO2019020810A1 (en) | 2019-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37824A (en) | CRYSTAL FORM OF ACID (2S) -2 - [[(Z) - [1- (2-AMINO-4-TIAZOLIL) -2 - [[(3S) -2,2-DIMETIL-4-OXO-1- ( SULFOXI) -3-AZETIDINIL] AMINO] -2-OXOETILIDEN] AMINO] OXI] -3- [4- [IMINO [(3R) -3-PIPERIDINYLAMINE] METHYL] PHENOXY] -PROPANOIC | |
CL2017000705A1 (en) | New compounds | |
AR116394A2 (en) | N- [5- (AMINOSULFONYL) -4-METHYL-1,3-THIAZOL-2-IL] -N-METHYL-2- [4- (2-PYRIDINYL) PHENYL] ACETAMIDE MONOHYDRATE MESILATE | |
CY1118435T1 (en) | MORPHOLINE NUCLEAR ACID PRODUCER | |
EA201592305A1 (en) | METHOD OF OBTAINING AND CRYSTAL FORMS OF MDM2 INHIBITOR | |
PE20170664A1 (en) | APELINE RECEPTOR AGONISTS (APJ) AND USES OF THE SAME | |
AR098929A1 (en) | CRYSTALLINE SOLID FORMS OF COMPOUND 2 - ((S) - (((2R, 3R, 4R, 5R) -5- (2,4-DIOXO-3,4-DIHYDROPIRIMIDIN-1 (2H) -IL) -4-FLUORO -3-HYDROXI-4-METHYLTHETRAHYDROFURAN-2-IL) METOXI) (PHENOXI) PHOSPHORILAMINE) PROPANOATE | |
PE20142403A1 (en) | BETA-LACTAMASE INHIBITORS COMPOUNDS | |
PE20140849A1 (en) | 3,5-DIAMINO-6-CHLORO-N- (N- (4- (4- (2- (HEXYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) ETHOXY) PHENYL) BUTYL) CARBAMIMIDOYL) PYRAZINE -2-CARBOXAMIDE | |
ES2723277T3 (en) | A solid form of (S) -3- (4 - ((4-morpholinomethyl) benzyl) oxy) -1-oxoisoindolin-2-yl) piperidine-2,6-dione hydrochloride | |
BR112015000160A2 (en) | Manufacture of 2- (5-bromo-4- (4-cyclopropylhydronaphthalen-1-yl) -4h-1,2,4-triazol-3-yl-thio) acetic acid | |
AR078944A1 (en) | N1-PIRAZOLOESPIROCETONA ACETIL-COA CARBOXYLASE INHIBITORS | |
MY172534A (en) | Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof | |
CO6210692A2 (en) | HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS | |
PE20090243A1 (en) | IMIDAZOLE COMPOUNDS SUBSTITUTED AS RENIN INHIBITORS | |
WO2014188453A3 (en) | Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid | |
CL2021000454A1 (en) | Method for preparing 2 - [(3r) -3-methylmofolin-4-yl] -4- (1-methyl-1h-pyrazol-5-yl) -8- (1h-pyrazol-5-yl) -1 , 7-naphthyridine | |
PE20061421A1 (en) | N-FORMIL-HYDROXYLAMINE COMPOUNDS AS PEPTIDYL-DEFORMYLASE INHIBITORS | |
CY1122506T1 (en) | CRYSTAL FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY- PYRIDIN-4- YL)-[1,2,4]OXADIAZOL-3- YL]-2- ETHYL- 6-METHYL- PHENOXY}-PROPANE-1,2-DIOL | |
ECSP11011081A (en) | 3-AMINOCICLOPENTANCARBOXAMIDAS | |
CO6260137A2 (en) | EPOXY COMPOUND AND METHOD TO MANUFACTURE THE SAME | |
CO6460700A2 (en) | PIRAZOL COMPOUND | |
CO6700844A2 (en) | New crystalline forms of (e) -3- (2- (1 - ((2- (5-bromo-pyrimidin-2-yl) -3- cyclopentyl-1 methyl-1h indole-6-carbonyl) -amino) -cyclobutyl-3-methyl-3h-bacimidazol-5 -) - acrylics as vhc inhibitors | |
MX365948B (en) | Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide. | |
NI200900154A (en) | NEW PROCEDURE FOR OBTAINING THE CRYSTALLINE V FORM OF AGOMELATIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20231110 |